Published in Mol Cell Endocrinol on February 01, 1988
Hepatic iodothyronine 5'-deiodinase. The role of selenium. Biochem J (1990) 1.24
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology (2000) 2.50
Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health (1998) 2.24
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev (2001) 1.69
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia (2005) 1.58
Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J (1976) 1.57
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med (1992) 1.54
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med (1991) 1.41
[Cardiovascular effects of hyperthyroidism and their treatment]. Ned Tijdschr Geneeskd (2002) 1.39
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver. J Nucl Med (1993) 1.38
Kinetic evidence suggesting two mechanisms for iodothyronine 5'-deiodination in rat cerebral cortex. Proc Natl Acad Sci U S A (1982) 1.37
Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol (1993) 1.34
Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J Clin Invest (1983) 1.30
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med (2001) 1.30
Cerebral cortex responds rapidly to thyroid hormones. Science (1981) 1.29
In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol (1998) 1.22
Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab (2001) 1.20
Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology (1996) 1.20
Sequential deiodination of thyroxine in rat liver homogenate. Biochem J (1978) 1.18
Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb. Neurosci Res (1995) 1.16
Inhibition of thyroid hormone sulfation by hydroxylated metabolites of polychlorinated biphenyls. Chem Biol Interact (1998) 1.15
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res (1998) 1.13
Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology (2001) 1.12
Thyroid hormone transporters. Biochem Soc Trans (2005) 1.10
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab (2003) 1.09
Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab (1998) 1.08
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med (1995) 1.08
Mechanism of action of iodothyronine-5'-deiodinase. Biochim Biophys Acta (1979) 1.08
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med (2001) 1.07
Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab (2008) 1.06
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab (1977) 1.06
Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology (2005) 1.05
Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol (Oxf) (1981) 1.05
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med (1997) 1.04
A tentative review of recent in vitro observations of the enzymatic deiodination of iodothyronines and its possible physiological implications. Mol Cell Endocrinol (1978) 1.04
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. Eur J Nucl Med (1999) 1.04
Evolution of pigeon Newcastle disease virus strains. Avian Pathol (2002) 1.03
Kinetics of enzymic reductive deiodination of iodothyronines. Effect of pH. Biochem J (1979) 1.03
Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology (1999) 1.02
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology (1991) 1.01
Identification of thyroid hormone transporters. Biochem Biophys Res Commun (1999) 1.00
Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Lett (1978) 1.00
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol (1992) 0.99
Regulation of thyroid hormone metabolism during fetal development. Mol Cell Endocrinol (1999) 0.98
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med (1997) 0.97
Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. Endocrinology (1984) 0.97
Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum. Biochim Biophys Acta (1979) 0.97
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol (2006) 0.96
Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase. FEBS Lett (1994) 0.96
Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development. J Clin Endocrinol Metab (2001) 0.95
Different pathways of iodothyronine 5'-deiodination in rat cerebral cortex. Biochem Biophys Res Commun (1981) 0.95
Kinetics of Ca2+ and Sr2+ uptake by yeast. Effects of pH, cations and phosphate. Biochim Biophys Acta (1979) 0.94
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology (1994) 0.94
Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology (1985) 0.94
Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. Endocrinology (1993) 0.94
Interlaboratory variation of vitamin D1) metabolite measurements. J Clin Chem Clin Biochem (1982) 0.94
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med (1995) 0.94
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history. Ann N Y Acad Sci (1994) 0.94
Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus. J Neurosci (1984) 0.93
Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology (1985) 0.93
Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) (2008) 0.92
Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab (2000) 0.92
Dronerarone acts as a selective inhibitor of 3,5,3'-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence. Endocrinology (2003) 0.92
Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid (2004) 0.91
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (1998) 0.91
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab (2011) 0.91
Substrate requirement for inactivation of iodothyronine-5'-deiodinase activity by thiouracil. Biochim Biophys Acta (1981) 0.91
Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol (1977) 0.90
Photophysics of the single tryptophan residue in Fusarium solani Cutinase: evidence for the occurrence of conformational substates with unusual fluorescence behaviour. Biophys Chem (1996) 0.90
In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: isozyme specificity and inhibition kinetics. Toxicol Sci (1998) 0.90
Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab (1996) 0.90
The VP2 variable region of African and German isolates of infectious bursal disease virus: comparison with very virulent, "classical" virulent, and attenuated tissue culture-adapted strains. Arch Virol (2000) 0.90
Hypothalamo-hypophysial-thyroid axis in streptozotocin-induced diabetes. Endocrinology (1992) 0.89
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J Nucl Med (1996) 0.89
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (2000) 0.88
Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers. Eur J Endocrinol (2009) 0.88
Rat liver type I iodothyronine deiodinase is not identical to protein disulfide isomerase. Biochem Biophys Res Commun (1989) 0.88
Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J (Clin Res Ed) (1981) 0.87
Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab (1999) 0.87
One enzyme for the 5'-deiodination of 3,3',5'-triiodothyronine and 3',5'-diiodothyronine in rat liver. Biochem Pharmacol (1982) 0.87
Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase. Endocrinology (1997) 0.86
Sulfation preceding deiodination of iodothyronines in rat hepatocytes. Science (1983) 0.86
Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child Fetal Neonatal Ed (2003) 0.86
Radiolabelled regulatory peptides for imaging and therapy. Anticancer Agents Med Chem (2007) 0.86
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy. Int J Cancer (1999) 0.86
Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats. Biochem Pharmacol (1993) 0.86
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours. Clin Endocrinol (Oxf) (2002) 0.86
Serum thyrotrophin concentration: an unreliable test for detection of early hypothyroidism after thyroidectomy. Br Med J (1975) 0.86
Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clin Endocrinol (Oxf) (2007) 0.86
Solubilization and partial characterization of rat liver iodothyronine deiodinases. Biochim Biophys Acta (1980) 0.85
Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives. Clin Endocrinol (Oxf) (1981) 0.85
Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism. Clin Endocrinol (Oxf) (1982) 0.85
Determinants of polychlorinated biphenyls (PCBs) in human milk. Acta Paediatr Scand (1988) 0.85
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy. Int J Cancer (1999) 0.85
Characterization of human iodothyronine sulfotransferases. J Clin Endocrinol Metab (1999) 0.85
Inhibition of iodothyronine 5'-deiodinase by thioureylenes; structure--activity relationship. FEBS Lett (1979) 0.85
Regulation of hypothalamic TRH production and release in the rat. Acta Med Austriaca (1992) 0.85
Uptake of triiodothyronine and triiodothyroacetic acid in neonatal rat cardiomyocytes: effects of metabolites and analogs. J Endocrinol (2002) 0.85